The fourth-quarter 2025 reporting season for the Medical sector is nearing its final stretch, with only a handful of pharma and biotech companies scheduled to report over the next two weeks. The ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...

Insmed has claimed the distinction of becoming the first company to get FDA approval for a treatment for chronic lung disease non-cystic fibrosis bronchiectasis (NCFB). The US regulator cleared DPP1 ...

Gentle stretching and traction-based exercises may help reduce Peyronie’s disease curvature by breaking down some scar tissue. More research is needed on newer devices. Penile traction therapy (PTT) ...

Kashif J. Piracha, MD, FACP, FASN, FNKF, is a practicing physician at Methodist Willowbrook Hospital. Acute bronchitis usually clears up on its own, but you may have a cough that lasts up to four ...